495 related articles for article (PubMed ID: 34034702)
1. DNA methylation signatures associated with prognosis of gastric cancer.
Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
[TBL] [Abstract][Full Text] [Related]
2. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
Li T; Chen X; Gu M; Deng A; Qian C
Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
[TBL] [Abstract][Full Text] [Related]
4. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
[TBL] [Abstract][Full Text] [Related]
5. High expression of
Du WB; Lin CH; Chen WB
World J Gastroenterol; 2019 Aug; 25(31):4452-4467. PubMed ID: 31496624
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
[TBL] [Abstract][Full Text] [Related]
8. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
10. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
[TBL] [Abstract][Full Text] [Related]
11. Predicting amplification of
Giwa A; Rossouw SC; Fatai A; Gamieldien J; Christoffels A; Bendou H
Future Oncol; 2021 Dec; 17(34):4769-4783. PubMed ID: 34751044
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
16. A DNA methylation signature to improve survival prediction of gastric cancer.
Peng Y; Wu Q; Wang L; Wang H; Yin F
Clin Epigenetics; 2020 Jan; 12(1):15. PubMed ID: 31959204
[TBL] [Abstract][Full Text] [Related]
17. A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer.
Wu R; Guo S; Lai S; Pan G; Zhang L; Liu H
BMC Cancer; 2021 Jun; 21(1):684. PubMed ID: 34112138
[TBL] [Abstract][Full Text] [Related]
18. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
[TBL] [Abstract][Full Text] [Related]
19. High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.
Sepulveda JL; Gutierrez-Pajares JL; Luna A; Yao Y; Tobias JW; Thomas S; Woo Y; Giorgi F; Komissarova EV; Califano A; Wang TC; Sepulveda AR
Mod Pathol; 2016 Feb; 29(2):182-93. PubMed ID: 26769141
[TBL] [Abstract][Full Text] [Related]
20. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients.
Woo Y; Behrendt CE; Yang A; Hahn M; Goel A; Li H; Yuan YC; Fong Y
J Am Coll Surg; 2021 Apr; 232(4):483-491.e1. PubMed ID: 33465468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
